Health and wellness brand company Wellnex Life has rejoined the local bourse under the code WNX following the completion of an 18-month strategic reshuffle of its operations and product ranges.

The relisting represents the culmination of months of work during which CEO George Karafotias has overseen the acquisition of Brand Solutions Australia and raised $2.2 million in new capital to fund Wellnex’s growth targets.

“The past 18 months have seen us completely reshape the old Wattle Health into something bold, new, and ready to meet Australia’s growing desire to better manage their own health,” Mr Karafotias said.

“Australia’s a health-conscious nation, we love the outdoors and we take our health pretty seriously, and stock markets reflect that – the local health and wellness market is a really interesting space and we expect to see it grow as investors recognise the opportunities it holds.

“I believe Wellnex Life is now poised to be a leader in the sector given our deep experience in the market and extensive R&D, product development, and distribution networks, Mr Karafotias said.

The company holds a diversified portfolio of 15 products and has three new product launches in the pipeline for the first half of the 2022 financial year.

The company has distribution agreements in place with several major health and wellness retailers including Chemist Warehouse (with which Wellnex Life has also entered into a joint venture), Priceline, Woolworths, Coles, Sigma, and Australian Pharmaceutical Industries (API).

This article is sponsored content. The supplier of this content has a commercial arrangement with Switzer Financial Group.